Skip to Content


In the US, Phenelzine (phenelzine systemic) is a member of the drug class monoamine oxidase inhibitors and is used to treat Depression and Migraine Prevention.

US matches:



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Category

Antidepressant: Inhibitor of monoamine oxidase type A (MAO-A)

Chemical Name

Hydrazine, (2-phenyletyl)-

Foreign Names

  • Phenelzinum (Latin)
  • Phenelzin (German)
  • Phénelzine (French)
  • Fenelzina (Spanish)

Generic Names

Brand Names

  • Nardelzine
    Pfizer, Belgium
  • Nardil
    Archimedes Pharma UK, United Kingdom; Link, Australia; Link, New Zealand; Pfizer U.S., United States


BANBritish Approved Name
BANMBritish Approved Name (Modified)
DCFDénomination Commune Française
ISInofficial Synonym
OSOfficial Synonym
PHPharmacopoeia Name
Prop.INNProposed International Nonproprietary Name (World Health Organization)

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.